BASF Coatings Unit Sale to Carlyle Approved by European Commission
65d ago|4 min readStandard
Fazen Markets Editorial Desk
Collective editorial team · methodology
basfcarlyle
Fazen Markets Editorial Desk
Collective editorial team · methodology
Trades XAUUSD on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. AiX is informational software — not investment advice. Past performance does not guarantee future results.
BASF SE announced on 3 June 2026 that the European Commission has granted unconditional antitrust approval for the sale of its coatings division to private equity firm Carlyle. The transaction, valued at an enterprise value of approximately EUR 2.7 billion, is a definitive step in the German chemical group's strategic pivot. The approval clears the final major regulatory hurdle for a deal initially announced in late 2025.
The divestiture aligns with a strategic shift for BASF, which first announced its intention to streamline its portfolio under the ‘BASF 4.0’ strategy in late 2024. The company is refocusing on core businesses like catalysts and battery materials while shedding more cyclical units. This mirrors a broader trend in the European chemical sector, where giants like Lanxess and Evonik have also pursued portfolio optimization to improve returns amid high energy costs and sluggish demand.
The approval arrives during a period of heightened regulatory scrutiny on chemical industry consolidation, particularly within the European Union. The Commission's unconditional green light signals a pragmatic approach to deals that do not materially reduce market competition. This decision reduces uncertainty for other pending transactions in the industrial goods and specialty materials space.
The primary catalyst for the sale was BASF's need to strengthen its balance sheet after a challenging 2025. The company faced margin compression from elevated natural gas prices in Europe and weaker demand from key end-markets like automotive and construction. Proceeds from the sale are earmarked for debt reduction and funding high-growth segments less exposed to economic cycles.
The transaction carries an enterprise value of EUR 2.7 billion. This represents a significant premium to the unit's estimated book value, which analysts pegged closer to EUR 2.0 billion. The sale price equates to roughly 8.5 times the division's estimated 2025 EBITDA of approximately EUR 320 million.
BASF's coatings business employs around 5,000 people globally and operates production sites in Europe, the Americas, and Asia. The unit generated sales of EUR 3.4 billion in the 2025 fiscal year. For comparison, leading pure-play coatings competitor PPG Industries reported 2025 sales of $18.2 billion.
The divestiture will reduce BASF's total annual revenue by approximately 7%. The company's net debt is projected to fall by over EUR 2 billion upon deal closure, expected in Q3 2026. This will lower BASF's leverage ratio, a key credit metric, from 2.8x EBITDA to an estimated 2.3x.
| Metric | Pre-Sale (FY2025) | Post-Sale (Pro Forma) |
|---|---|---|
| Group Sales | ~EUR 49bn | ~EUR 45.6bn |
| Net Debt | ~EUR 16.8bn | ~EUR 14.8bn |
| Leverage Ratio (Net Debt/EBITDA) | 2.8x | 2.3x |
The approval is a clear positive for BASF (BAS.DE, BASFY) as it removes a key execution risk. The stock may see a relief rally, with a near-term price target of EUR 55, representing a 5% upside from current levels. The deal enhances BASF's financial flexibility, allowing for increased investment in its more profitable battery materials division.
Specialty chemical peers with complex portfolios, such as Lanxess (LXS.DE) and Clariant (CLN.SW), may also see investor pressure to pursue similar value-unlocking divestitures. The transaction sets a valuation benchmark for coatings assets, potentially benefiting companies like AkzoNobel (AKZA.AS). Private equity appetite for stable, cash-generative industrial assets remains strong, as evidenced by Carlyle's winning bid.
A key risk is integration execution for Carlyle. The private equity firm must manage potential customer attrition and manage the business through an industrial downturn. The cyclical nature of the coatings business, tied to automotive and construction volumes, presents a headwind that Carlyle's financial engineering must overcome.
Hedge funds had built small net short positions in BASF ahead of the decision, betting on regulatory delays. The approval will likely trigger a short covering flow. Long-only institutional investors are expected to rotate into BASF from more diversified, lower-yielding chemical conglomerates.
Market attention now shifts to the formal closing of the transaction, anticipated before the end of Q3 2026. The exact date will be confirmed following customary closing conditions. The deployment of the EUR 2.7 billion in proceeds will be a critical indicator of management's capital allocation discipline.
BASF's Q2 2026 earnings report, scheduled for 30 July 2026, will provide the first detailed pro-forma financial outlook excluding the coatings unit. Analysts will scrutinize guidance for the remaining businesses, particularly any upward revisions for the battery materials segment. The company's mid-year strategy update may also reveal further portfolio adjustments.
Technical levels to monitor for BASF stock include a key support zone at EUR 48, its 200-day moving average. A sustained break above resistance at EUR 55 would signal strong bullish conviction in the refocused strategy. The STOXX Europe 600 Chemicals Index (SX4P) will be a relevant sector benchmark.
For retail investors, the sale simplifies the BASF investment thesis. The company is becoming a more focused play on high-growth areas like battery materials and catalysts, shedding a slower-growth, capital-intensive business. This could lead to a higher valuation multiple over time, similar to pure-play peers. The debt reduction also lowers the company's financial risk profile.
The transaction is comparable in strategic intent to DowDuPont's historic separation into three companies in 2019. In terms of size, it is smaller than Linde's $5 billion asset sale to Messer in 2018 but larger than most recent European chemical spin-offs. The EUR 2.7 billion valuation represents a premium multiple, reflecting strong private equity demand for resilient industrial assets with strong cash flow.
The European Commission has generally been permissive with vertical integrations and portfolio divestitures that do not create horizontal overlaps. A key precedent is the 2019 approval of the BASF-Solvay polyamide deal, which required minor remedies. The unconditional approval for BASF-Carlyle suggests the Commission viewed the coatings unit as a standalone business with sufficient competitive pressure from giants like PPG and Sherwin-Williams.
The European Commission's approval solidifies BASF's strategic pivot toward less cyclical, higher-margin specialty chemicals.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.
AiX is our free MetaTrader 4 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. XAUUSD breakout engine.
Trade 800+ global stocks & ETFs
Start TradingSponsored
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
